Dr. Nuno Arantes-Oliveira is a Venture Partner at ALCEA ADVISORS.
Nuno is a seasoned executive and entrepreneur with a keen interest in technological innovation, particularly in healthcare. Among other ventures, Nuno was the founding CEO of ATGC Portugal, which became a leading tech-transfer company in the Country; of Alfama, Inc. (based in Cambridge, Mass. and Lisbon), a drug development company voted best startup in Europe and sold to Proterris, Inc., of Boston; and of Coimbra Genomics S.A., named one of Europe’s top-3 promises in e-Health.
Nuno was President of P-BIO – Portugal’s Biotechnology Industry Organization (2011-2015, now Chairman) and sat on the board of Health Cluster Portugal (2008-2013). He has had board and advisory roles in technology-based ventures, public agencies and top-tier research organizations in various countries, and has negotiated and implemented business and scientific collaborations in Europe, the US, China, Africa and Latin America. His personal business interests and holdings range from healthcare services to marine biotechnology and personalized medicine.
Currently Nuno is an invited assistant professor of the MIT-Portugal Program, where he helps highly skilled graduate students from the world over to think as innovators and as entrepreneurs. Nuno obtained his own PhD in Genetics with pioneer work on the molecular basis of aging and lifespan regulation, performed at the University of California San Francisco (UCSF) and published in very high impact journals.